Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05999006 · ClinicalTrials.gov registry record · NA
Safety and Feasibility of the ELIOS System in POAG Patients
A NA study of Glaucoma, Primary Open Angle, sponsored by Elios Vision.
- Recruiting
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 5
- Study locations
NCT05999006 is a NA study of Glaucoma, Primary Open Angle that is actively recruiting participants, run by Elios Vision. The registered enrollment target is 65 participants, above the 58-participant average among 5 other Glaucoma, Primary Open Angle trials with a reported enrollment target (12% higher). The trial reports 5 study locations across 5 states.
The verdict
NCT05999006, a NA study of Glaucoma, Primary Open Angle, is actively recruiting participants, sponsored by Elios Vision.
- RECRUITING
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 5
- Study locations
Study Summary
Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG)
Conditions Studied
Interventions
- DEVICE ELIOS Procedure
Study Locations (5)
Arizona
- Elios Vision Clinical Site - Glendale
Florida
- Elios Vision Clinical Site - Largo
Illinois
- Elios Vision Clinical Site - Rock Island
Oklahoma
- Elios Vision Clinical Site - Oklahoma City
Wisconsin
- Elios Vision Clinical Site - Kenosha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2023-10-18 |
| Est. Completion | 2026-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05999006
The ClinicalTrials.gov registry entry for NCT05999006 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 58-participant average among 5 other Glaucoma, Primary Open Angle trials with a reported enrollment target (12% higher). The listed sponsor is Elios Vision, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Glaucoma, Primary Open Angle appearing as the primary indexed condition, and to 1 intervention - of which ELIOS Procedure is the first listed.
NCT05999006 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT05999006 about?
NCT05999006 is a clinical study titled "Safety and Feasibility of the ELIOS System in POAG Patients". Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG)
What is the current status of trial NCT05999006?
This trial is currently recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2023-10-18. Estimated completion is 2026-04.
What conditions does trial NCT05999006 study?
This clinical trial studies the following conditions: Glaucoma, Primary Open Angle.
What interventions are being tested in trial NCT05999006?
The interventions under investigation include: ELIOS Procedure (DEVICE).
Who is sponsoring clinical trial NCT05999006?
This trial is sponsored by Elios Vision, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05999006 being conducted?
This trial has 5 study locations across Arizona, Florida, Illinois, Oklahoma, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma, Primary Open Angle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adaptive Optics Retinal Imaging
RECRUITING · NA
-
Caffeine Consumption in Glaucoma Patients and Healthy Subjects
RECRUITING · NA
-
Safety and IOP-Lowering Effects of WB007
COMPLETED · Phase 1
-
Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert
COMPLETED · Phase 4
-
NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.